medigraphic.com
ISSN 1527-3172 (Electronic)

2020, Number 3

<< Back Next >>

MEDICC Review 2020; 22 (3)

Prognostic Scale to Stratify Risk of Intrahospital Death in Patients with Acute Myocardial Infarction with ST Segment Elevation

Rodríguez-Jiménez AE, Negrín-Valdés T, Cruz-Inerarity H, Castellano-Gallo LA, Chávez-González E

Language: English
References: 50
Page: 46-53
PDF size: 111.88 Kb.


ABSTRACT

INTRODUCTION The scales available to predict death and complications after acute coronary syndrome include angiographic studies and serum biomarkers that are not within reach of services with limited resources. Such services need specifi c and sensitive instruments to evaluate risk using accessible resources and information.
OBJECTIVE Develop a scale to estimate and stratify the risk of intrahospital death in patients with acute ST-segment elevation myocardial infarction.
METHODS An analytical observational study was conducted in a universe of 769 patients with acute ST-segment elevation myocardial infarction who were admitted consecutively to the Camilo Cienfuegos Provincial Hospital in Sancti Spíritus Province, Cuba, from January 2013 to March 2018. The fi nal study cohort included 667 patients, excluding 102 due to branch blocks, atrial fi brillation, drugs that prolong the QT interval, low life expectancy or history of myocardial infarction. The demographic variables of age, sex, skin color, classic cardiovascular risk factors, blood pressure, heart rate, blood glucose level, in addition to duration and dispersion of the QT interval with and without correction, left ventricular ejection fraction, and glomerular fi ltration rate were included in the analysis. Patients were categorized according to the Killip-Kimball Classification for degree of heart failure. A risk scale was constructed, the predictive ability of which was evaluated using the detectability index associated with an receiver-operator curve.
RESULTS Seventy-seven patients died (11.5%). Mean blood glucose levels were higher among the deceased, while their systolic and diastolic blood pressure, left ventricular ejection fraction, and glomerular fi ltration rate were lower than those participants discharged alive. Relevant variables included in the scale were systolic blood pressure, Killip-Kimball class, cardiorespiratory arrest, glomerular fi ltration rate, corrected QT interval dispersion, left ventricular ejection fraction, and blood glucose levels. The variable with the best predictive ability was cardiorespiratory arrest, followed by a blood glucose level higher than 11.1 mmol/L. The scale demonstrated a great predictive ability with a detectability index of 0.92.
CONCLUSIONS The numeric scale we designed estimates and stratifi es risk of death during hospitalization for patients with ST-segment elevation myocardial infarction and has good metric properties for predictive ability and calibration.


REFERENCES

  1. World Health Statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019 [cited 2019 Oct 2]. Available at: https://www.who.int/gho/ publications/world_health_statistics/2019/en/

  2. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J [Internet]. 2018 Jan 7 [cited 2019 Oct 2];39(2):119–77. Available at: https://doi .org/10.1093/eurheartj/ehx393

  3. O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, De Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol [Internet]. 2013 [cited 2019 Oct 2];61(4):e78–e140. Available at: https://doi.org/10.1016/j.jacc.2012.11.019

  4. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report from the American Heart Association. Circulation [Internet]. 2019 Mar 5 [cited 2019 Oct 2];139(10):e56–e528. Available at: https://doi .org/10.1161/CIR.0000000000000659

  5. Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med [Internet]. 2017 May 25 [cited 2019 Oct 2];376(21):2053–64. Available at: https://doi.org/10.1056/NEJMra1606915

  6. National Health Statistics and Medical Records Division (CU). Anuario Estadístico de Salud 2018. Havana: Ministry of Public Health (CU); 2019 [cited 2019 Jun 1]. 205 p. Available at: http://fi les.sld.cu/bvscuba/fi les/2019/04/Anuario -Electr%C3%B3nico-Espa%C3%B1ol-2018-ed -2019-compressed.pdf. Spanish.

  7. Sanz GA. Estratifi cación del riesgo en los síndromes coronarios agudos: un problema no resuelto. Rev Esp de Cardiol [Internet]. 2007 [cited 2018 Mar 17];60 Suppl 3:23–30. Available at: https://www.revespcardiol.org/en-pdf-13113980. Spanish.

  8. Buccheri S, Capranzano P, Condorelli A, Scalia M, Tamburino C, Capodanno D. Risk stratifi cation after ST-segment elevation myocardial infarction. Expert Rev Cardiovasc Ther [Internet]. 2016 Dec [cited 2019 Oct 2];14(12):1349–60. Available at: http://dx.doi.org/10.1080/14779072 .2017.1256201

  9. Song PS, Ryu DR, Kim MJ, Jeon KH, Choi RK, Park JS, et al. Risk scoring system to assess outcomes in patients treated with contemporary guideline-adherent optimal therapies after acute myocardial infarction. Korean Cir J [Internet]. 2018 Jun [cited 2019 Oct 2];48(6):492–504. Available at: https://e-kcj.org/DOIx.php?id=10.4070/ kcj.2017.0128

  10. McNamara RL, Kennedy KF, Cohen DJ, Diercks DB, Moscucci M, Ramee S, et al. Predicting inhospital mortality in patients with acute myocardial infarction. J Am Coll Cardiol [Internet]. 2016 Aug 9 [cited 2019 Oct 2];68(6):626–35. Available at: http://dx.doi.org/10.1016/j.jacc.2016.05.049

  11. Morrow DA, Antman EM, Giugliano RP, Cairns R, Charlesworth A, Murphy SA, et al. A simple risk index for rapid initial triage of patients with STelevation myocardial infarction: an InTIME II substudy. Lancet [Internet]. 2001 Nov 1 [cited 2019 Oct 2];358(9293):1571–5. Available at: https:// doi.org/10.1016/S0140-6736(01)06649-1

  12. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation [Internet]. 2000 Oct 24 [cited 2019 Oct 2];102(17):2031–7. Available at: https://doi.org/10.1161/01.cir.102.17.2031

  13. Shimony A, Grandi SM, Pilote L, Joseph L, O’Loughlin J, Paradis G, et al. Utilization of evidence-based therapy for acute coronary syndrome in high-income and low/middle-income countries. Am J Cardiol [Internet]. 2014 Mar 1 [cited 2019 Oct 2];113(5):793–7. Available at: https://dx.doi.org/10.1016/j.amjcard.2013.11.024

  14. Rosselló X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol [Internet]. 2017 Oct 15 [cited 2019 Oct 2];245:27–34. Available at: https:// dx.doi.org/10.1016/j.ijcard.2017.07.039

  15. Brogan RA, Malkin CJ, Batin PD, Simms AD, McLenachan JM, Gale CP. Risk stratifi cation for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. World J Cardiol [Internet]. 2014 Aug 26 [cited 2019 Oct 2];6(8):865–73. Available at: https://dx.doi.org/10.4330/wjc.v6.i8.865

  16. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med [Internet]. 2003 Oct 27 [cited 2019 Oct 2];163(19):2345–53. Available at: http://doi.org/10.1001/archinte .163.19.2345

  17. D’Ascenzo F, Biondi-Zoccai G, Moretti C, Bollati M, Omedè P, Sciuto F, et al. TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials [Internet]. 2012 May [cited 2019 Oct 2];33(3):507–14. Available at: https://dx.doi.org/10.1016/j.cct.2012.01 .001

  18. Ridker PM, Libby P, Buring JE. Risk Markers and the Primary Prevention of Cardiovascular Disease. In: Zipes DP, Libby P, Bonow RO, Mann DL, Tomaselli GF, editors. Braunwald´s Heart disease. A textbook of cardiovascular medicine. 11th ed. Philadelphia: Elsevier; 2019. p.876–905.

  19. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol [Internet]. 1967 Oct [cited 2019 Oct 2];20(4):457–64. Available at: https://doi.org /10.1016/0002-9149(67)90023-9

  20. Center for State Control of Medicines, Equipment and Medical Devices - CECMED (CU). Heberkinasa (Estreptoquinasa recombinante) Liofi lizado para inyección (IV o IC). Titular del Registro Sanitario, Centro de Ingeniería Genética y Biotecnología (CIGB), Cuba. Número de Registro Sanitario: Heberkinasa® 1 500 000 UI: 1507. Fecha de Inscripción: Heberkinasa® 1 500000 UI. 20 de marzo de 2000 [Internet]. Havana: Center for State Control of Medicines, Equipment and Medical Devices - CECMED (CU); 2000 Mar [cited 2019 Oct 2]. Available at: https://www.cec med.cu/registro/rcp/heberkinasar-1-500-000-ui -estreptoquinasa-recombinante. Spanish.

  21. Bayés de Luna A. Bases de la electrocardiografía. De las variantes de la normalidad a los patrones diagnósticos (III): Isquemia, lesión y necrosis. Vol 3. Barcelona: Prous Science; 2007.129 p. Spanish.

  22. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal defi nition of myocardial infarction (2018). J Am Coll Cardiol [Internet]. 2018 Oct 30 [cited 2019 Oct 2];72(18):2231–64. Available at: https://doi .org/10.1016/j.jacc.2018.08.1038

  23. Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr [Internet]. 2019 Jan [cited 2019 Oct 2];32(1):1–64. Available at: http://dx.doi.org/10.1016/j.echo .2018.06.004

  24. Teruel JLG, Catalán SB. Valoración de afección renal, disfunción renal aguda e hiperpotasemia por fármacos usados en cardiología y nefrotoxicidad por contrastes. Rev Esp Cardiol [Internet]. 2011 Dec 1 [cited 2019 Oct 2];64(12):1182–92. Available at: https://doi.org/10.1016/j.recesp .2011.08.012. Spanish.

  25. Center for State Control of Medicines, Equipment and Medical Devices - CECMED (CU). Registro de electrocardiógrafo digital de tres canales. Titular del Registro Sanitario, Instituto Central de Investigación Digital ICID. Fecha de Inscripción: 2008 febrero 28 [Internet]. Havana: Center for State Control of Medicines, Equipment and Medical Devices - CECMED (CU); 2008 Feb 28 [cited 2018 Sep 2]. 55 p. Available at: http://www.cecmed.cu/ sites/default/files/adjuntos/registro_equipos_m/ registro_em_2004_2007.pdf. Spanish.

  26. Postema PG, Wilde AAM. The measurement of the QT interval. Curr Cardiol Rev [Internet]. 2014 Aug [cited 2019 Oct 2];10(3):287–94. Available at: https://doi.org/10.2174/157340 3X10666140514103612

  27. Smulyan H. QT interval: Bazett’s Correction corrected. J Electrocardiol [Internet]. 2018 Nov–Dec [cited 2019 Oct 2];51(6):1009–10. Available at: http://dx.doi.org/10.1016/j.jelectro card.2018.08.013

  28. Stankovic I, Putnikovic B, Janicijevic A, Jankovic M, Cvjetan R, Pavlovic S, et al. Myocardial mechanical and QTc dispersion for the detection of signifi cant coronary artery disease. Eur Heart J Cardiovasc Imaging [Internet]. 2015 Sep [cited 2019 Oct 2];16(9):1015–22. Available at: http:// dx.doi.org/10.1093/ehjci/jev029

  29. Acosta Martínez J, Berruezo A. Abordajes alternativos a la fracción de eyección en la estratifi cación de riesgo de arritmias ventriculares. Cardiocore [Internet]. 2017 Jan–Mar [cited 2019 Oct 2];52(1):7–10. Available at: http://dx.doi .org/10.1016/j.carcor.2016.12.002. Spanish.

  30. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA [Internet]. 2013 Nov 27 [cited 2018 Jun 13];310(20):2191–4. Available at: https://jamanetwork.com/journals/jama/full article/10.1001/jama.2013.281053

  31. Van Delden JJM, Van der Graaf R. Revised CIOMS International Ethical Guidelines for Health-Related Research Involving Humans. JAMA [Internet]. 2017 Jan 10 [cited 2019 Sep 11];317(2):135–6. Available at: https://jamanet work.com/journals/jama/article-abstract/2592245

  32. Helmy H, Abdel-Galeel A, Taha Kishk Y, Mohammed Sleem K. Correlation of corrected QT dispersion with the severity of coronary artery disease detected by SYNTAX score in non-diabetic patients with STEMI. Egypt Heart J [Internet]. 2017 Jun [cited 2019 Oct 2];69(2):111–7. Available at: http://dx.doi.org/10.1016/j.ehj.2016.12.001

  33. Huang J, Peng X, Fang Z, Hu X, Zhou S. Risk assessment model for predicting ventricular tachycardia or ventricular fi brillation in ST-segment elevation myocardial infarction patients who received primary percutaneous coronary intervention. Medicine [Internet]. 2019 Jan [cited 2019 Oct 2];98(4):e14174. Available at: https://dx.doi .org/10.1097/MD.0000000000014174

  34. Yu Z, Chen Z, Wu Y, Chen R, Li M, Chen X, et al. Electrocardiographic parameters effectively predict ventricular tachycardia/fi brillation in acute phase and abnormal cardiac function in chronic phase of ST–segment elevation myocardial infarction. J Cardiovasc Electrophysiol [Internet]. 2018 May [cited 2019 Oct 2];29(5):756–66. Available at: http://dx.doi.org/10.1111/jce.13453

  35. Rodríguez-Jiménez AE, Cruz-Inerarity H, Negrin- Valdés T, Fardales-Rodríguez R, Chávez- González E. Corrected QT-interval dispersion: an electrocardiographic tool to predict recurrence of myocardial infarction. MEDICC Rev [Internet]. 2019 Apr–Jul [cited 2019 Oct 2];21(2–3):22–8. Available at: http://mediccreview.org/wp-content/ uploads/2019/07/MR-AprilJuly2019-OR-rodri guez-corrected-qt.pdf

  36. Rivera-Fernández R, Arias-Verdú MD, García- Paredes T, Delgado-Rodríguez M, Arboleda- Sánchez JA, Aguilar-Alonso E, et al. Prolonged QT interval in ST-elevation myocardial infarction and mortality: new prognostic scale with QT, Killip and age. J Cardiovasc Med [Internet]. 2016 Jan [cited 2019 Oct 2];17(1):11–9. Available at: https://doi.org/10.2459/JCM.0000000000000015

  37. Bordejevic DA, Caruntu F, Mornos C, Olariu I, Petrescu L, Tomescu MC, et al. Prognostic impact of blood pressure and heart rate at admission on in-hospital mortality after primary percutaneous intervention for acute myocardial infarction with ST-segment elevation in western Romania. Ther Clin Risk Manag [Internet]. 2017 Aug 23 [cited 2019 Oct 2];13:1061–8. Available at: http://dx.doi.org/10.2147/TCRM.S141312

  38. Vavalle JP, van Diepen S, Clare RM, Hochman JS, Weaver WD, Mehta RH, et al. Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: predictors, clinical and angiographic features, and outcomes. Am Heart J [Internet]. 2016 Mar 1[cited 2019 Oct 2];173:57–66. Available at: http://dx.doi .org/10.1016/j.ahj.2015.12.001

  39. Gutiérrez HB, Martos Benítez FD. Valor pronóstico de la función renal a corto plazo en pacientes con infarto agudo de miocardio. Rev Colombiana Cardiol [Internet]. 2018 Jan 1 [cited 2019 Oct 2];25(1):26–32. Available at: https://doi. org/10.1016/j.rccar.2017.08.013. Spanish.

  40. Pocock S, Bueno H, Licour M, Medina J, Zhang L, Annemans L, et al. Predictors of one-year mortality at hospital discharge after acute coronary syndromes: a new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns in acute coronary syndrome patients) study. Eur Heart J Acute Cardiovasc Care [Internet]. 2015 Dec [cited 2019 Oct 2];4(6):509–17. Available at: http://dx.doi.org /10.1177/2048872614554198

  41. Ding XS, Wu SS, Chen H, Zhao XQ, Li HW. High admission glucose levels predict worse shortterm clinical outcome in non-diabetic patients with acute myocardial infraction: a retrospective observational study. BMC Cardiovasc Disord [Internet]. 2019 Jul 4 [cited 2019 Oct 2];19(1):163. Available at: https://doi.org/10.1186/s12872-019 -1140-1

  42. Kojima T, Hikoso S, Nakatani D, Suna S, Dohi T, Mizuno H, et al. Impact of hyperglycemia on longterm outcome in patients with ST-segment elevation myocardial infarction. Am J Cardiol [Internet]. 2020 Mar 15 [cited 2020 Mar 20]. Available at: https://doi.org/10.1016/j.amjcard.2019.12.034

  43. Kosiborod M. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Endocrinol Metab Clin North Am [Internet]. 2018 Mar [cited 2019 Oct 2];47(1):185–202. Available at: https://doi.org/10.1016/j.ecl.2017.11.002

  44. Bhar-Amato J, Davies W, Agarwal S. Ventricular Arrhythmia after Acute Myocardial Infarction: ‘The Perfect Storm’. Arrhythm Electrophysiol Rev [Internet]. 2017 Aug [cited 2019 Oct 2];6(3):134–9. Available at: http://dx.doi.org/10.15420/aer.2017.24.1

  45. Farré N, Fort A, Tizón-Marcos H, Recasens L, Vaquerizo B, Serrat R, et al. Epidemiology of heart failure in myocardial infarction treated with primary angioplasty: Analysis of the Codi IAM registry. REC: CardioClinics [Internet]. 2019 Jan– Mar [cited 2019 Oct 2];54(1):41–9. Available at: https://doi.org/10.1016/j.rccl.2019.01.014

  46. Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, et al. Causes and predictors of 30-day readmission in patients with acute myocardial infarction and cardiogenic shock. Circ Heart Fail [Internet]. 2018 Apr [cited 2019 Oct 2];11(4):e004310. Available at: http://dx.doi .org/10.1161/CIRCHEARTFAILURE.117.004310

  47. Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, et al. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: fi ndings from the NCDR. J Am Coll Cardiol [Internet]. 2016 Feb 23 [cited 2019 Oct 2];67(7):739–47. Available at: http://dx.doi.org/10.1016/j.jacc.2015.11.048

  48. Bedetti G, Gargani L, Sicari R, Gianfaldoni ML, Molinaro S, Picano E. Comparison of prognostic value of echocardiographic risk score with the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry in Acute Coronary Events (GRACE) risk scores in acute coronary syndrome. Am J Cardiol [Internet]. 2010 Dec 15 [cited 2019 Oct 2];106(12):1709–16. Available at: https://doi.org/10.1016/j.amjcard.2010.08.024

  49. Schwaiger JP, Reinstadler SJ, Tiller C, Holzknecht M, Reindl M, Mayr A, et al. Baseline LV ejection fraction by cardiac magnetic resonance and 2D echocardiography after ST-elevation myocardial infarction – infl uence of infarct location and prognostic impact. Eur Radiol [Internet]. 2020 [cited 2020 Feb 21];30(1):663–71. Available at: https://link.springer.com/content/pdf/10. 1007%2Fs00330-019-06316-3.pdf

  50. Argimon-Pallas JM, Jiménez-Villa J. Métodos de investigación clínica y epidemiológica. 5th ed. Barcelona: Elsevier; 2019. 496 p. Spanish.




2020     |     www.medigraphic.com